Related Experiment Video
Updated: Jul 16, 2026
05:46
Correction of Presbyopia by Monocular Bi-Aspheric Ablation Profile
Published on: September 20, 2024
Visual performance results after Tetraflex accommodating intraocular lens implantation
Donald R Sanders1, Monica L Sanders
1Center for Clinical Research, Elmhurst, Illinois 60126, USA.
Ophthalmology
|March 21, 2007
Summary
The Tetraflex accommodating intraocular lens (IOL) effectively improves both distance and near vision. Clinical results show significant enhancement in visual acuity six months post-surgery.
Area of Science:
- Ophthalmology
- Biomedical Engineering
- Clinical Research
Background:
- Cataract surgery often involves intraocular lens (IOL) implantation to restore vision.
- Accommodating IOLs aim to mimic the natural eye's ability to focus at different distances.
- The Tetraflex IOL is designed to provide improved visual function post-cataract surgery.
Purpose of the Study:
- To evaluate the clinical efficacy of the Tetraflex accommodative intraocular lens (IOL).
- To assess the IOL's capability in enhancing both distance and near visual acuity.
Main Methods:
- Prospective, single-center study involving 59 patients (95 eyes) undergoing Tetraflex IOL implantation.
- Data collection included uncorrected and best-corrected visual acuities (distance and near), refractive error, and accommodative amplitude.
- Intraoperative and postoperative complications were also monitored.
Main Results:
- At 6 months, 63% of patients achieved 20/40 or better distance-corrected near visual acuity (DCNVA).
- Nearly all patients (98-100%) demonstrated at least 1 diopter (D) of accommodative amplitude, with 75.7% achieving ≥2 D at 6 months.
- Uncorrected distance visual acuity (UCDVA) of 20/40 or better was achieved by 92.2% of eyes at 6 months or later.
Conclusions:
- The Tetraflex accommodating IOL demonstrates effectiveness in enhancing near vision.
- Good distance vision is also achieved, with high percentages of patients meeting visual acuity benchmarks.
- The study supports the Tetraflex IOL as a viable option for improved visual outcomes after cataract surgery.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...